Skip to main content

ALTERNATE trial: No fulvestrant benefit in locally advanced ER+ HER2– breast cancer

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
ALTERNATE trial: No fulvestrant benefit in locally advanced ER+ HER2– breast cancer

User login

Username

Password

Reset your password

Type	Lead	score